游离DNA筛查时代早孕期超声的价值
回顾性队列研究分析2013年10月1日至2014年10月1日1906例早孕期超声,检出胎儿、妇科及胎盘异常分别为42例(2.2%)、286例(15.0%)、317例(16.6%);游离DNA与侵入性检测结果不一致8/61例(13%),与超声发现不一致18/42例(42%);若仅用游离DNA筛查,将漏检超声所检出胎儿异常的95%。
要点
- 早孕期超声可检出胎儿、妇科及胎盘异常,提供游离DNA无法获得的解剖信息。
- 游离DNA与侵入性检测结果不一致8/61例(13%),与超声发现不一致18/42例(42%)。
- 仅以游离DNA作为早孕期筛查方法将漏检超声所检出胎儿异常的95%。
核心结论
- 全面的早孕期超声可提供游离DNA无法检测的胎儿及母体解剖相关的有价值临床信息。
研究设计与样本
- 回顾性队列研究,纳入在母胎医学转诊机构接受早孕期超声的患者,分析超声检出的胎儿、妇科及胎盘发现与现有游离DNA及诊断性检测结果。
主要发现
- 2013年10月1日至2014年10月1日共1906例早孕期超声,959例(50%)有游离DNA结果。
- 早孕期超声检出胎儿发现42例(2.2%)、妇科发现286例(15.0%)、胎盘发现317例(16.6%)。
- 游离DNA与侵入性检测结果不一致8/61例(13%),与超声发现不一致18/42例(42%)。
- 诊断性检测确认6例游离DNA假阳性和2例假阴性。
- 亚组分析显示,仅以游离DNA作为早孕期筛查方法将漏检超声所检出胎儿发现的95%。
临床怎么用
- 原文结论认为全面的早孕期超声可提供游离DNA无法检测的胎儿及母体解剖相关临床信息。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To describe the clinically relevant findings detected by the first trimester ultrasound (FTU) and to determine the additional value of the FTU compared to cell free DNA (cfDNA) alone. METHOD: Retrospective cohort study of patients undergoing a FTU at a maternal-fetal medicine referral practice. Fetal, gynecologic, and placental findings detected by ultrasound were analyzed with available cfDNA and diagnostic testing results. A subgroup analysis of positive ultrasound findings and cfDNA results was performed to assess the additional benefit of ultrasound evaluation in FT prenatal screening. RESULTS: There were 1906 FTU between 1 October 2013 and 1 October 2014. CfDNA results were available for 959 (50%) patients. FTU detected: 42 fetal (2.2%), 286 gynecologic (15.0%), and 317 placental (16.6%) findings. CfDNA results were discordant with invasive testing results in 8/61 cases (13%) and with ultrasound findings in 18/42 (42%) cases. There were six false positive and two false negative cfDNA results confirmed by diagnostic testing. Subgroup analysis revealed that cfDNA as the sole method of prenatal screening in the FT would miss 95% of the fetal findings detected with ultrasound. CONCLUSION: The comprehensive FTU provides valuable clinical information about fetal and maternal anatomy that cannot be detected with cfDNA alone. © 2016 John Wiley & Sons, Ltd.
引用
- Rao RR, Valderramos SG, Silverman NS, et al. The value of the first trimester ultrasound in the era of cell free DNA screening. Prenat Diagn. 2016. PMID: 27813114. doi:10.1002/pd.4955
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。